Also known as: Lopidine
Apraclonidine is indicated for:
Population group: both men and women, only adults (18 years old or older)
Apraclonidine is indicated for short-term adjunctive therapy of chronic glaucoma in patients on maximally tolerated medical therapy who require additional intraocular pressure (IOP) reduction to delay laser treatment or glaucoma surgery.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Apraclonidine is contraindicated in the following cases: